Literature DB >> 23210113

Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients.

Sarah N Hilmer1, Danijela Gnjidic, David G Le Couteur.   

Abstract

BACKGROUND: Medicines in older patients have the potential to provide great gains as well as significant harms.
OBJECTIVE: To provide an ethically sound, evidence based discussion of the benefits and harms of medications commonly used in primary care among older patients. DISCUSSION: Appropriate prescribing and deprescribing (drug withdrawal) for older patients requires a thorough understanding of the individual, their therapeutic goals, the benefits and risks of all of their medicines, and medical ethics. There is very limited evidence on the safety and efficacy of medicines in older adults, particularly in the frail, who often have multiple comorbidities and functional impairments. In robust older patients, therapy usually aims to delay or cure disease and to minimise functional impairment. In frail older patients, symptom control, maintaining function and addressing end-of-life issues become the main priorities. Optimising medicines is a time-consuming, multidisciplinary process that requires extensive communication, frequent monitoring and review, and has a major clinical impact.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23210113

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  28 in total

1.  Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems.

Authors:  Sara Modig; Lydia Holmdahl; Åsa Bondesson
Journal:  Int J Clin Pharm       Date:  2015-11-18

Review 2.  Age-Related Changes in Hepatic Function: An Update on Implications for Drug Therapy.

Authors:  Joseph L Tan; Jacques G Eastment; Arjun Poudel; Ruth E Hubbard
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

3.  Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.

Authors:  Katie Qi; Emily Reeve; Sarah N Hilmer; Sallie-Anne Pearson; Slade Matthews; Danijela Gnjidic
Journal:  Int J Clin Pharm       Date:  2015-06-06

4.  A comparison of medical and pharmacy students' knowledge and skills of pharmacology and pharmacotherapy.

Authors:  Sarah N Hilmer; J Paul Seale; Peter R Carroll
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 5.  A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.

Authors:  Emily Reeve; Danijela Gnjidic; Janet Long; Sarah Hilmer
Journal:  Br J Clin Pharmacol       Date:  2015-12       Impact factor: 4.335

6.  The Ethics of Deprescribing in Older Adults.

Authors:  Emily Reeve; Petra Denig; Sarah N Hilmer; Ruud Ter Meulen
Journal:  J Bioeth Inq       Date:  2016-07-14       Impact factor: 1.352

7.  Is the Drug Burden Index Related to Declining Functional Status at Follow-up in Community-Dwelling Seniors Consulting for Minor Injuries? Results from the Canadian Emergency Team Initiative Cohort Study.

Authors:  Edeltraut Kröger; Marilyn Simard; Marie-Josée Sirois; Marianne Giroux; Caroline Sirois; Lisa Kouladjian-O'Donnell; Emily Reeve; Sarah Hilmer; Pierre-Hugues Carmichael; Marcel Émond
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 8.  Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review.

Authors:  Ian A Scott; Peter I Pillans; Michael Barras; Christopher Morris
Journal:  Ther Adv Drug Saf       Date:  2018-07-12

9.  Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.

Authors:  Emily Reeve; Sepehr Shakib; Ivanka Hendrix; Michael S Roberts; Michael D Wiese
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

10.  Benefits of deprescribing on patients' adherence to medications.

Authors:  Emily Reeve; Michael D Wiese
Journal:  Int J Clin Pharm       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.